Martin F. Schacker

Vorstandsvorsitzender bei Tetragenex Pharmaceuticals, Inc.

65 Jahre

Health Technology

Finance

Consumer Services

Aktive Positionen von Martin F. Schacker

Unternehmen	Position	Beginn	Ende
Tetragenex Pharmaceuticals, Inc. Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY.	Vorstandsvorsitzender	05.02.2010	-
	Vorsitzender	05.02.2010	-

Unternehmen	Position	Beginn	Ende
M.S. Farrell & Co., Inc.	Vorsitzender	02.02.2001	02.02.2001
M.S. Farrell & Co., Inc.	Präsident	-	02.02.2001
D.H. Blair & Co.	Corporate Officer/Principal	02.12.1991	02.12.1991
Lehman Brothers Holdings Plc Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK.	Corporate Officer/Principal	02.05.1987	02.05.1987

Hofstra University

Undergraduate Degree

International

Vereinigte Staaten	5
Vereinigtes Königreich	2

Operativ

Chairman	2
Corporate Officer/Principal	2
Chief Executive Officer	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	4
Tetragenex Pharmaceuticals, Inc. Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY.	Health Technology
M.S. Farrell & Co., Inc.
D.H. Blair & Co.
Lehman Brothers Holdings Plc Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK.	Finance